MIRCERA

Indicated For

anemia associated with chronic kidney disease (CKD)

About This Medication

# CSL Vifor Patient Assistance Program: How to Get MIRCERA at Low or No Cost ## About This Program MIRCERA (methoxy polyethylene glycol-epoetin beta) is a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease (CKD).[2] If you have been prescribed MIRCERA but are struggling with the cost, CSL Vifor may be able to help through their patient assistance program. ## What is MIRCERA? MIRCERA is indicated for the treatment of anemia in adult patients on dialysis and adult patients not on dialysis, as well as pediatric patients 3 months to 17 years of age on dialysis or not on dialysis who are converting from another ESA after their hemoglobin level was stabilized with an ESA.[1] This medication helps your body produce red blood cells, which carry oxygen throughout your body. ## Who Can Apply? While specific income thresholds and eligibility criteria for the CSL Vifor patient assistance program are not detailed in available resources, patient assistance programs typically serve individuals with demonstrated financial need who lack adequate insurance coverage. To determine your eligibility, you should contact CSL Vifor directly. ## How to Apply To apply for assistance with MIRCERA, follow these steps: 1. **Contact CSL Vifor** by calling **1-800-576-8295** or emailing **mircera@viforpharma.com**[1] 2. **Speak with a program representative** who can explain eligibility requirements and guide you through the application process 3. **Gather required documentation**, which typically includes proof of income, proof of residency, and your prescription from your healthcare provider 4. **Complete the application form** with assistance from the program representative if needed 5. **Submit your application** along with all required documents ## What You'll Need to Apply While the search results do not specify exact documentation requirements for the MIRCERA program, typical patient assistance applications require: - Proof of U.S. residency - Recent proof of income (pay stubs, tax returns, or benefit statements) - Proof of financial hardship if applicable - A valid prescription from your healthcare provider - Insurance information (if you have coverage) When you call, ask the program representative for a complete list of documents needed for your specific situation. ## Insurance Requirements Patient assistance programs are typically designed for uninsured or underinsured patients. If you have insurance, the program may still be available to you depending on your coverage and out-of-pocket costs. Contact CSL Vifor at 1-800-576-8295 to discuss your specific insurance situation. ## Timeline and Delivery The search results do not specify the processing timeline for MIRCERA patient assistance applications or delivery methods. When you contact CSL Vifor, ask about: - How long approval typically takes - How your medication will be delivered - Whether expedited processing is available if medically necessary ## What Happens If Your Application is Denied If your application is denied, ask the program representative: - The specific reason for denial - Whether you can reapply with additional information - What alternative assistance programs might be available - Whether your healthcare provider can appeal the decision ## Reauthorization and Refills The search results do not specify reauthorization requirements for the MIRCERA patient assistance program. When approved, ask about: - How long your assistance will last - Whether you need to reapply after a certain period - How to request refills - What happens if your financial situation changes ## Important Information About MIRCERA Before starting MIRCERA, your healthcare provider will monitor your hemoglobin levels. If you experience a lack or loss of hemoglobin response to MIRCERA, your doctor will investigate potential causes such as iron deficiency, infection, inflammation, or bleeding.[2] In rare cases, patients may develop pure red cell aplasia (PRCA), a serious condition requiring immediate medical attention. If you develop PRCA, MIRCERA must be permanently discontinued, and you should not switch to other ESAs as antibodies may cross-react.[7] ## Contact Information **CSL Vifor Patient Assistance:** - Phone: 1-800-576-8295[1] - Email: mircera@viforpharma.com[1] Call during business hours to speak with a representative who can answer your questions and help you apply. ## Disclaimer This guide provides general information about patient assistance programs for MIRCERA. Eligibility, requirements, and program details may change. For the most current and accurate information about the CSL Vifor patient assistance program, contact CSL Vifor directly at the phone number or email listed above. This guide is not a guarantee of assistance or approval. Your healthcare provider should always be involved in decisions about your MIRCERA treatment.

Program information last verified: March 30, 2026